Literature DB >> 1375075

Zinc bone loss in chronic renal failure and chronic metabolic acidosis.

A Caldas1, M J Richard, S Maniar, D Laouari, M Dechaux, A Favier, C Kleinknecht.   

Abstract

The effects of chronic metabolic acidosis (CMA) on zinc (Zn) bone content and urinary excretion were examined in the presence of normal or reduced renal function together with some aspects of calcium (Ca) metabolism. Four groups of rats were compared. All were fed a 30% protein and 9 mg Zn/100 g diet. Two were uremic (U): The first developed acidosis (UA), which was suppressed in the other (UNA) by NaHCO3 supplement. Two other groups had normal renal function: One was normal (CNA), and the other had NH4Cl in the drinking water and acidosis (CA). Femur total Zn and Ca content was markedly reduced by CMA and was not affected by uremia. Zn urinary excretion was increased by CMA and unaltered by uremia. Ca urinary excretion was markedly reduced in uremic rats, but was enhanced in both acidotic conditions. Urinary Ca and Zn showed a strong correlation in uremic and in control rats. Plasma parathormone and 1,25(OH)2D3 were unchanged by CMA. These data are in agreement with a direct primary effect of CMA on bone in releasing buffers. CMA induces bone resorption and a parallel decrease of mineral bone components, such as Ca and Zn, with little or no role of PTH, 1,25(OH)2D3 and of uremia itself.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375075     DOI: 10.1007/bf02784620

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  40 in total

1.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

2.  Binding of zinc to amino acids and serum proteins in vitro.

Authors:  A S Prasad; D Oberleas
Journal:  J Lab Clin Med       Date:  1970-09

3.  Zinc metabolism in renal failure.

Authors:  C J Condon; R M Freeman
Journal:  Ann Intern Med       Date:  1970-10       Impact factor: 25.391

4.  Improvement of uremic hypogeusia by zinc: a double-blind study.

Authors:  S K Mahajan; A S Prasad; J Lambujon; A A Abbasi; W A Briggs; F D McDonald
Journal:  Am J Clin Nutr       Date:  1980-07       Impact factor: 7.045

5.  The effects of metabolic acidosis on bone formation and bone resorption in the rat.

Authors:  J A Kraut; D R Mishler; F R Singer; W G Goodman
Journal:  Kidney Int       Date:  1986-11       Impact factor: 10.612

6.  Trace element abnormalities in chronic uremia.

Authors:  W R Smythe; A C Alfrey; P W Craswell; C A Crouch; L S Ibels; H Kubo; L L Nunnelley; H Rudolph
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

7.  Serum concentrations and urinary excretions of zinc in cirrhosis, nephrotic syndrome and renal insufficiency.

Authors:  R D Lindeman; D J Baxter; A A Yunice; S Kraikitpanitch
Journal:  Am J Med Sci       Date:  1978 Jan-Feb       Impact factor: 2.378

8.  Alterations in calcium, magnesium, iron, and zinc metabolism by dietary cholestyramine.

Authors:  D W Watkins; R Khalafi; M M Cassidy; G V Vahouny
Journal:  Dig Dis Sci       Date:  1985-05       Impact factor: 3.199

9.  The effect of metabolic acidosis on vitamin D metabolites and bone histology in uremic rats.

Authors:  Y L Chan; E Savdie; R S Mason; S Posen
Journal:  Calcif Tissue Int       Date:  1985-03       Impact factor: 4.333

10.  Hair zinc compared with plasma zinc in uremic patients before and during regular hemodialysis.

Authors:  T Mountokalakis; D Dakanalis; D Boukis; K Virvidakis; S Voudiklari; A Koutselinis
Journal:  Clin Nephrol       Date:  1979-11       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.